The Neopentylamine Market size is projected to grow at a CAGR of 5.1% during the forecast period 2022-2027 and reach US$2.1 billion by 2027. Neopentylamine is a primary amine derivative of neopentane and it is also known as 1-amino-2, 2-dimethylpropane or 2,2-dimethylpropylamine. It is mainly used in the pharmaceutical and chemical industries. The expansion of the Neopentylamine Market is primarily driven by its usage in the pharmaceutical industry. In 2020, the onset of the COVID-19 pandemic led to strict lockdowns all over the world, which interrupted the entire supply and trade of raw materials from manufacturing hubs. This, in turn, resulted in slow developments and manufacturing in the pharmaceutical sector, thus, temporarily affecting the growth of the global neopentylamine industry. However, a steady recovery in pharmaceutical production has been witnessed since 2021, which is driving the demand for neopentylamine. According to the Brazilian Chemical Industry Association, the production of the pharmaceutical industry in Brazil was valued at US$16.1 billion in 2021, an increase of 2.6% from US$15.7 billion in 2020. An increase in pharmaceutical production along with the growth of the chemical industry is expected to drive the growth of the Neopentylamine Market size in the upcoming years. On the other hand, health hazards associated with the use of Neopentylamine may confine the growth of the market.
Neopentylamine Market Report Coverage
The "Neopentylamine Market Report – Forecast (2022-2027)” by IndustryARC, covers an in-depth analysis of the following segments in the global Neopentylamine Market.
Key Takeaways
- More than 97% purity segment held a significant share in the Neopentylamine Market in 2021. Its wide range of characteristics along with its higher physical and chemical properties made it stand out in comparison to other types of synthesis methods in the market.
- The Pharmaceutical industry held the largest share in the Neopentylamine Market in 2021. The anti-inflammatory properties of Neopentylamine make them ideal for use as pharmaceutical intermediates utilized in the industry.
- Asia-Pacific dominated the Neopentylamine Market in 2021, owing to the increasing demand for Neopentylamine from the pharmaceutical sector in the region.
- A detailed analysis of strengths, weaknesses, opportunities and threats would be provided in the Neopentylamine Market Report.
Neopentylamine Market Segment Analysis – by Purity
More than 97% purity segment held a share of over 20% in the Neopentylamine Market in 2021. This is fueled by the increasing demand for neopentylamine due to the benefits it offers over other types of purity. For instance, higher-purity neopentylamine of more than 97% has very low impurities and allows manufacturers to make mass production as well as active pharmaceutical ingredients. Moreover, higher-purity neopentylamine of more than 97% helps in creating precise and distinct pharmaceutical and chemical formulations as compared to other types of lower-purity neopentylamine. Furthermore, high-purity neopentylamine of more than 97% has higher chemical and physical properties that are ideal for use in the pharmaceutical and chemical sectors. Hence, all of these properties are driving its demand over other types of purity, which in turn, is expected to boost the market growth during the forecast period.
Neopentylamine Market Segment Analysis – by End-use Industry
The pharmaceutical industry held the largest share of over 25% in the Neopentylamine Market in 2021, owing to the increasing production from pharmaceutical sectors across the world. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total production of pharmaceuticals including capsules, tablets and other products in Europe was valued at EUR 310,000 million (approx. US$354,080.76 million) in 2020. Moreover, according to the Government of Japan Ministry of Health, the total pharmaceutical production in Japan reached US$84.6 million in 2020.
Neopentylamine (also known as 1-amino-2, 2-dimethylpropane or 2,2-dimethylpropylamine) is a primary amine derivative of neopentane. Due to its anti-inflammatory properties, it is primarily used as a pharmaceutical intermediate or active pharmaceutical ingredient utilized during the production of pharmaceutical drugs and medicines. Thus, such surging production from the pharmaceutical sector across the world is expected to increase the demand for neopentylamine. This is expected to expand the Neopentylamine Market size during the forecast period.
Neopentylamine Market Segment Analysis – by Geography
Asia-Pacific dominated the Neopentylamine Market with a 35% share in 2021. The consumption of neopentylamine is particularly high in this region due to its increasing demand from the pharmaceutical sector. According to the General Statistics Office of Vietnam, the total pharmaceutical production in Vietnam was valued at US$3484.5 million in 2020, an increase of around 7% from US$3255.6 million in 2019. According to Vietnam’s Ministry of Health, the pharmaceutical industry is expected to grow at a rate of 10% per year from 2017 to 2028. This is due to an increase in pharmaceutical production and sales in the country. Furthermore, according to India Brand Equity Foundation (IBEF), India ranked 3rd in terms of pharmaceutical production by volume in 2021. It further states that the domestic pharmaceutical industry in India includes around 3,000 drug companies and approx. 10,500 manufacturing units. This is expected to accelerate market growth during the forecast period.
Neopentylamine Market Drivers
An increase in pharmaceutical production:
Neopentylamine (also known as 1-amino-2, 2-dimethylpropane or 2,2-dimethylpropylamine) is a primary amine derivative of neopentane. It is primarily used as a pharmaceutical intermediate or active pharmaceutical ingredient utilized during the production of pharmaceutical drugs and medicines. The anti-inflammatory properties of neopentylamine make it ideal for use in such pharmaceutical applications. According to the Government of Japan Ministry of Health, Labor and Welfare (MHLW), the production of pharmaceuticals in Japan was valued at US$87.03 million in 2019, an increase of 39% in comparison to the previous year. Moreover, recent insights from the International Trade Administration state that the total consumption of pharmaceutical products in Mexico reached up to US$11.1 billion in 2020, representing an increase of 2.8% from US$10.8 billion in 2019. Hence, such an increase in pharmaceutical production is expected to increase the demand for neopentylamine, owing to its above-mentioned properties and usage. This is anticipated to drive the growth of the market in the upcoming years.
Growth of the chemical industry:
Neopentylamine is commonly utilized in the chemical industry for use in chemical reagents needed for various types of chemical analysis, during the preparation and production of chemicals. According to the American Chemistry Council, Inc., the production of industrial chemicals increased significantly by 5.9% in 2021 as compared to 2020. It further states that the total production from the chemical industry in the U.S. is expected to increase by up to 4.3% in 2022. Furthermore, according to the European Chemical Industry Council, the total chemical sales in Europe accounted for 18.1% of global chemical sales in 2020. Similarly, Asia, excluding China, Japan and South Korea, accounted for 15.4%, while Latin America accounted for 2.7% of the global sales in 2020. Hence, such surging growth of the global chemical industry is expected to increase the demand for Neopentylamine for use in chemical reagents during the preparation and production of chemicals.
Neopentylamine Market Challenges
Health hazards associated with the use of Neopentylamine:
Neopentylamine is considered to be hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200). Its contact with acids releases very toxic gas. Furthermore, inhalation of vapors or fumes generated by the material during the course of normal handling may produce severely toxic effects which may be fatal. In case of contact with the eye, it may cause eye irritation or serious eye damage in acute cases. In addition to this, severe cough, headache, nausea and shortness of breath are some of the common symptoms associated with prolonged exposure to neopentylamine. In severe cases, it may cause skin corrosion, organ toxicity and failure of the respiratory system. Thus, such health hazards associated with the use of neopentylamine may limit the growth of the global Neopentylamine Industry during the forecast period.
Neopentylamine Industry Outlook
Technology launches, acquisitions and increased R&D activities are key strategies adopted by players in the Neopentylamine Market. The top companies in the Neopentylamine Market are:
- TCI Chemicals
- Alfa Chemistry
- 3B Scientific Corporation
- Apollo Scientific
- City Chemicals
- VWR International
- ChongQing Purel Bio-Pharmaceutical Technology
- J & K Scientific
- Beijing Ouhe Technology
- Shanghai Longsheng Chemical
- "We also publish more than 100 reports every month in “Chemicals and Materials”, Go through the Domain if there are any other areas for which you would like to get a market research study."
